| abstract |
An injectable composition of higher residual effect with reduced detrimental effects such as pain at injection site, swelling, tissue irritancy or necrosis and containing as active principle a tetracycline compound, either as the free base or a salt thereof with a physiologically acceptable acid, complexed with a substantially equimolar amount of a magnesium compound, is solubilised in a water miscible solvent system comprising, either (i) a) glycerol formal in an amount of from about 10 to about 50 % v/v; with b) polyethylene glycol in an amount of from about 1 to 15 % v/v; or (ii) from about 25 to about 75 % v/v of N-methylpyrrolidone, said composition optionally containing a pH modifier in an amount sufficient to maintain a physiochemically acceptable pH, the balance being made up with water q.s. |